Staging soft tissue sarcoma: evolution and change.

CA Cancer J Clin 2006 Sep-Oct;56(5):282-91; quiz 314-5

The University of TexasMD Anderson Cancer Center, Houston, TX, USA.

Soft tissue sarcoma (STS) is an extremely heterogeneous group of rare tumors that share a putative mesenchymal cell origin. STS can occur in any soft tissue in the body, yet all share a common feature of primarily disseminating hematogenously, particularly to the lungs. Staging for STS is particularly useful in prognosis, design of effective multimodality treatment programs, and comparing treatment outcomes from different centers and different eras. The current iteration of AJCC STS staging includes Tumor, Grade, Node, and Metastasis with "a" indicating superficial and "b" indicating deep designations. Further opportunities to improve this process exist, particularly as molecular considerations become more apparent, and future evolution into an even more useful STS staging system can be anticipated.

Download full-text PDF

Source
http://dx.doi.org/10.3322/canjclin.56.5.282DOI Listing
November 2006
5 Reads

Publication Analysis

Top Keywords

soft tissue
12
sts staging
8
tissue sarcoma
8
sts
5
design effective
4
designations opportunities
4
prognosis design
4
multimodality treatment
4
programs comparing
4
treatment programs
4
staging
4
opportunities improve
4
effective multimodality
4
staging sts
4
feature disseminating
4
metastasis "a"
4
common feature
4
disseminating hematogenously
4
improve process
4
comparing treatment
4

Similar Publications